Clinical Trial Update: Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/3 study sponsored by Rhode Island Hospital aims to identify the optimal buprenorphine dose for treating opioid use disorder and preventing overd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Opioid Use Disorder | Phase 2, Phase 3 | Status: RECRUITING